Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-25-000202
Filing Date
2025-10-30
Accepted
2025-10-29 17:38:45
Documents
101
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebs-20250930.htm   iXBRL 10-Q 2078571
2 EX-10.2 redactedmod13-acam2000.htm EX-10.2 1242
3 EX-10.3 feacam_75a50119c00071xmo.htm EX-10.3 28506
4 EX-31.1 a311-papacert093025.htm EX-31.1 8503
5 EX-31.2 a312-lindahlcert093025.htm EX-31.2 8563
6 EX-32.1 a321-papacert093025.htm EX-32.1 3444
7 EX-32.2 a322-lindahlcert093025.htm EX-32.2 3394
13 ebs-20250930_g1.jpg GRAPHIC 75656
14 feacam_75a50119c00071xmo001.jpg GRAPHIC 238226
15 feacam_75a50119c00071xmo002.jpg GRAPHIC 86300
16 feacam_75a50119c00071xmo003.jpg GRAPHIC 159372
17 redactedmod13-acam2000001.jpg GRAPHIC 225274
18 redactedmod13-acam2000002.jpg GRAPHIC 86973
19 redactedmod13-acam2000003.jpg GRAPHIC 56473
  Complete submission text file 0001367644-25-000202.txt   11399648

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20250930.xsd EX-101.SCH 62572
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20250930_cal.xml EX-101.CAL 85903
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20250930_def.xml EX-101.DEF 336011
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20250930_lab.xml EX-101.LAB 752855
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20250930_pre.xml EX-101.PRE 561037
104 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20250930_htm.xml XML 1672733
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 251431253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)